Abstract:Background: The primary cause of ischemic heart failure (HF) is myocardial infarction (MI) resulting in left ventricle (LV) wall motion abnormality secondary to ventricular remodeling. A prospective, nonrandomized study conducted in China was designed to assess safety and efficacy of the percutaneous ventricular restoration therapy using Parachute device (CardioKinetix, Inc., CA, USA) in ischemic HF patients as a result of LV remodeling after anterior wall MI. Methods: Thirty-one patients with New York Heart Association (NYHA) Class II, III ischemic HF, ejection fraction between 15% and 40%, and dilated akinetic or dyskinetic anterior-apical wall without the need to be revascularized were enrolled from seven sites in China from October to December 2014. The Parachute device was implanted through femoral artery. All patients received low-dose aspirin and anticoagulation with warfarin for at least 12 months postdevice implantation. The primary end-point was the assessment of efficacy as measured by the reduction in LV end-systolic volume index (LVESVI) against baseline LVESVI at 3 months postdevice implantation, determined by the echocardiography and measured by echocardiography core laboratory. Quality of life was assessed using EQ-5D and visual analog scale (VAS). For quantitative data comparison, paired t-test (normality data) and signed-rank test (abnormality data) were used; application of signed-rank test was for the ranked data comparison. Results: A change in LVESVI as measured by echocardiography from the preimplant baseline to 3-month postdevice implantation revealed a statistically significant reduction from 77.5 +/- 20.0 ml/m2 to 53.1 +/- 17.0 ml/m2 (P<0.0001). The trial met its primary end-point. Of the 31 patients, the procedural success was 96.8%. Overall, NYHA HF class assessment results showed an improvement of more than half a class at 3 months (P<0.001). Quality of life assessed by the VAS value increased 11.5 points (P<0.01), demonstrating improvement at 3 months. Conclusion: The favorable outcomes observed in the high-risk patients provide reassuring safety and efficacy data to support adoption of this technology as a therapeutic option for ischemic HF patients.

Temporary Cardiac Pacing Experiment in Self-Developed Intervention Treatment Shelter in Maneuver Environment

Cardiac Pacemaker Survey-Twenty Hospitals Pacemaker Implantation Registry in China

A Multi-Lead ECG Monitoring Combined with a Programmed Intracavitary ECG to Complete LBBaP Pacing: Study Protocol for a Single-center, Prospective Study

Long-term Safety and Feasibility of Permanent His Bundle Pacing

Clinical record analysis of 54 cases with automatic external defibrillator in public of mainland china

Novel Miniature Mobile Cardiac Catheterization Laboratory for Critical Cardiovascular Disease Following Natural Disasters: A Feasibility Study

The Application of Implantation Temporary Cardiac Pacing by Balloon-Tipped Floating Catheter for the Peroperative Period Patients

In Vivo Characterization of Attachment Safety Between Cardiac Pacing Lead and Canine Heart Muscle

Use of transcutaneous external pacing during transvenous pacemaker implantation in dogs

"Pacing Bigeminal" An Alternative Method In Developing A Rapid Pacing-Induced Heart Failure Model

Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study.

"Pacing Bigeminal".

Fully implantable and bioresorbable cardiac pacemakers without leads or batteries

Utility and cost effectiveness of temporary cardiac pacing using permanent leads and an externally placed reusable pacemaker

Nursing Mode Exploring of Treating Closed Hepatic Trauma and Hemorrhage by Percutaneous Coronary Intervention in Field Minimally-Invasive Interventional Shelter

Establishment and implementation effect of rapid response medical team for extracorporeal cardiopulmonary resuscitation in emergency department

A transient, closed-loop network of wireless, body-integrated devices for autonomous electrotherapy

The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions

Open-chest Pulsed Electric Field Ablation of Cardiac Ganglionated Plexi in Acute Canine Models

Effects of Cardiac Massage and β-Blocker Pretreatment on the Success Rate of Cardiopulmonary Resuscitation Assessed by the Canine Ischemia/Reperfusion-Induced Ventricular Fibrillation Model

In Vivo Mechanical Study of Helical Cardiac Pacing Electrode Interacting with Canine Myocardium